MORE►
Colossal Biosciences
Colossal co-founder and CEO Ben Lamm. [Image: Colossal]
The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer
by David Seeley | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
by David Seeley |
Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
by Quincy Preston and David Seeley |
Mar 22, 2022
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE►
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
